Shopping Cart 0
Cart Subtotal
USD 0

Advanced Proteome Therapeutics Corp (APC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-specific protein modification technology platform for the development of proprietary human protein pharmaceuticals with enhanced therapeutic properties and greater affinity for the target cancer cells and tumors. The patent pending technology combines anti-cancer therapies in a single agent to directly target cancerous tumors and avoid destroying normal cells. The company carries out its operations through its subsidiary; Advanced Proteome Therapeutics Inc. APC is headquartered in Boston, Massachusetts, the US.

Advanced Proteome Therapeutics Corp (APC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Advanced Proteome Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 10

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Advanced Proteome Raises USD0.1 Million in Venture Financing 13

Advanced Proteome Raises USD0.2 Million in Venture Financing 14

Advanced Proteome Raises USD0.3 Million in Venture Financing 15

Advanced Proteome Therapeutics Raises USD 0.04 Million In Venture Financing 16

Partnerships 17

Advanced Proteome Therapeutics Enters into Collaboration Agreement with Noria Pharma 17

Advanced Proteome Enters into Agreement with ImmunoBiochem 18

Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 19

Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 20

Licensing Agreements 21

Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 21

Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 22

Equity Offering 23

Advanced Proteome Therapeutics Raises USD0.2 Million in First Tranche Private Placement of Units 23

Advanced Proteome Raises USD0.1 Million in Second Tranche of Private Placement of Units 24

Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 25

Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 26

Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 27

Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 28

Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 29

Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 31

Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 32

Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 33

Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 34

Advanced Proteome Therapeutics Completes Private Placement Of Shares For USD 0.2 Million 35

Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.7 Million 36

Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.3 Million 37

Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For USD 0.2 Million 38

Advanced Proteome Therapeutics Corp-Key Competitors 39

Advanced Proteome Therapeutics Corp-Key Employees 40

Advanced Proteome Therapeutics Corp-Locations And Subsidiaries 41

Head Office 41

Other Locations & Subsidiaries 41

Recent Developments 42

Corporate Communications 42

Jun 06, 2018: Advanced Proteome Therapeutics Names Bill Dickie As Chief Executive Officer, President And Director 42

Apr 24, 2018: Advanced Proteome Therapeutics Announces Appointment of Scientific Advisory Board Members 43

Apr 16, 2018: Advanced Proteome Therapeutics Appoints New Board Members 44

Apr 16, 2018: Advanced Proteome Therapeutics Announces Resignation Of Randal Chase As CEO And Director 45

Jul 31, 2017: Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update 46

Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team 47

Product News 48

Jun 18, 2018: Advanced Proteome Therapeutics Advances its Technological Capability 48

Other Significant Developments 49

Sep 11, 2018: Advanced Proteome Therapeutics provides overview of current activities and strategic objectives 49

May 01, 2018: Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018 50

Jan 31, 2018: Advanced Proteome Therapeutics Announces Anti-Cancer R&D Gathers Momentum 51

Appendix 52

Methodology 52

About GlobalData 52

Contact Us 52

Disclaimer 52


List Of Figure

List of Figures

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Advanced Proteome Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Advanced Proteome Therapeutics Corp, Deals By Therapy Area, 2012 to YTD 2018 9

Advanced Proteome Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 10

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Advanced Proteome Raises USD0.1 Million in Venture Financing 13

Advanced Proteome Raises USD0.2 Million in Venture Financing 14

Advanced Proteome Raises USD0.3 Million in Venture Financing 15

Advanced Proteome Therapeutics Raises USD 0.04 Million In Venture Financing 16

Advanced Proteome Therapeutics Enters into Collaboration Agreement with Noria Pharma 17

Advanced Proteome Enters into Agreement with ImmunoBiochem 18

Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 19

Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 20

Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 21

Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 22

Advanced Proteome Therapeutics Raises USD0.2 Million in First Tranche Private Placement of Units 23

Advanced Proteome Raises USD0.1 Million in Second Tranche of Private Placement of Units 24

Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 25

Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 26

Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 27

Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 28

Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 29

Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 31

Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 32

Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 33

Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 34

Advanced Proteome Therapeutics Completes Private Placement Of Shares For USD 0.2 Million 35

Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.7 Million 36

Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.3 Million 37

Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For USD 0.2 Million 38

Advanced Proteome Therapeutics Corp, Key Competitors 39

Advanced Proteome Therapeutics Corp, Key Employees 40

Advanced Proteome Therapeutics Corp, Other Locations 41

Advanced Proteome Therapeutics Corp, Subsidiaries 41

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Advanced Proteome Therapeutics Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-specific protein modification technology platform for the development of proprietary human protein pharmaceuticals with enhanced therapeutic properties and greater affinity for the target cancer cells and tumors. The patent pending technology combines anti-cancer therapies in a single agent to directly target cancerous tumors and avoid destroying normal cells. The company carries out its operations through its subsidiary; Advanced Proteome Therapeutics Inc. APC is headquartered in Boston, Massachusetts, the US.

Advanced Proteome Therapeutics Corp (APC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Advanced Proteome Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 10

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Advanced Proteome Raises USD0.1 Million in Venture Financing 13

Advanced Proteome Raises USD0.2 Million in Venture Financing 14

Advanced Proteome Raises USD0.3 Million in Venture Financing 15

Advanced Proteome Therapeutics Raises USD 0.04 Million In Venture Financing 16

Partnerships 17

Advanced Proteome Therapeutics Enters into Collaboration Agreement with Noria Pharma 17

Advanced Proteome Enters into Agreement with ImmunoBiochem 18

Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 19

Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 20

Licensing Agreements 21

Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 21

Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 22

Equity Offering 23

Advanced Proteome Therapeutics Raises USD0.2 Million in First Tranche Private Placement of Units 23

Advanced Proteome Raises USD0.1 Million in Second Tranche of Private Placement of Units 24

Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 25

Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 26

Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 27

Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 28

Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 29

Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 31

Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 32

Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 33

Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 34

Advanced Proteome Therapeutics Completes Private Placement Of Shares For USD 0.2 Million 35

Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.7 Million 36

Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.3 Million 37

Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For USD 0.2 Million 38

Advanced Proteome Therapeutics Corp-Key Competitors 39

Advanced Proteome Therapeutics Corp-Key Employees 40

Advanced Proteome Therapeutics Corp-Locations And Subsidiaries 41

Head Office 41

Other Locations & Subsidiaries 41

Recent Developments 42

Corporate Communications 42

Jun 06, 2018: Advanced Proteome Therapeutics Names Bill Dickie As Chief Executive Officer, President And Director 42

Apr 24, 2018: Advanced Proteome Therapeutics Announces Appointment of Scientific Advisory Board Members 43

Apr 16, 2018: Advanced Proteome Therapeutics Appoints New Board Members 44

Apr 16, 2018: Advanced Proteome Therapeutics Announces Resignation Of Randal Chase As CEO And Director 45

Jul 31, 2017: Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update 46

Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team 47

Product News 48

Jun 18, 2018: Advanced Proteome Therapeutics Advances its Technological Capability 48

Other Significant Developments 49

Sep 11, 2018: Advanced Proteome Therapeutics provides overview of current activities and strategic objectives 49

May 01, 2018: Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018 50

Jan 31, 2018: Advanced Proteome Therapeutics Announces Anti-Cancer R&D Gathers Momentum 51

Appendix 52

Methodology 52

About GlobalData 52

Contact Us 52

Disclaimer 52


List Of Figure

List of Figures

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Advanced Proteome Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Advanced Proteome Therapeutics Corp, Deals By Therapy Area, 2012 to YTD 2018 9

Advanced Proteome Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 10

Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Advanced Proteome Raises USD0.1 Million in Venture Financing 13

Advanced Proteome Raises USD0.2 Million in Venture Financing 14

Advanced Proteome Raises USD0.3 Million in Venture Financing 15

Advanced Proteome Therapeutics Raises USD 0.04 Million In Venture Financing 16

Advanced Proteome Therapeutics Enters into Collaboration Agreement with Noria Pharma 17

Advanced Proteome Enters into Agreement with ImmunoBiochem 18

Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 19

Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 20

Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 21

Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 22

Advanced Proteome Therapeutics Raises USD0.2 Million in First Tranche Private Placement of Units 23

Advanced Proteome Raises USD0.1 Million in Second Tranche of Private Placement of Units 24

Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 25

Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 26

Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 27

Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 28

Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 29

Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 31

Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 32

Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 33

Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 34

Advanced Proteome Therapeutics Completes Private Placement Of Shares For USD 0.2 Million 35

Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.7 Million 36

Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.3 Million 37

Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For USD 0.2 Million 38

Advanced Proteome Therapeutics Corp, Key Competitors 39

Advanced Proteome Therapeutics Corp, Key Employees 40

Advanced Proteome Therapeutics Corp, Other Locations 41

Advanced Proteome Therapeutics Corp, Subsidiaries 41

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Advanced Proteome Therapeutics Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.